Targeted Therapies in Oncology

March 2021

February 2, 2021
Volume: 10
Issue: 3

February 1, 2021
Volume: 10
Issue: 2

January 2021
Volume: 10
Issue: 1

December 2, 2020
Volume: 9
Issue: 18

December 1 2020
Volume: 9
Issue: 17

November 2 2020
Volume: 9
Issue: 16

November 1 2020
Volume: 9
Issue: 15

October 2 2020
Volume: 9
Issue: 14

October 1, 2020
Volume: 9
Issue: 13

September 1 2020
Volume: 9

August 1 2020
Volume: 9
Issue: 1

July 1 2020
Volume: 9
Issue: 9

July 2 2020
Volume: 9
Issue: 10

June 1 2020
Volume: 9
Issue: 8

May 1 2020
Volume: 9
Issue: 5

April 2 2020
Volume: 9
Issue: 6

April 1 2020
Volume: 9
Issue: 5

March 1 2020
Volume: 9
Issue: 4

February 2 2020
Volume: 9
Issue: 3

February 1 2020
Volume: 9
Issue: 2

January 2020
Volume: 9
Issue: 1
December 2
Volume: 8
Issue: 18

December 1
Volume: 8
Issue: 17

November 2 2019
Volume: 8
Issue: 16

November 1 2019
Volume: 8
Issue: 15

October 2 2019
Volume: 8
Issue: 14

October 2019
Volume: 8
Issue: 13

September 2019
Volume: 8
Issue: 12

August 2019
Volume: 8
Issue: 11
Advertisement
Advertisement
Trending on Targeted Onc
1
Galinpepimut-S Improves Overall Survival in Phase 3 REGAL Trial in AML
2
FDA Approves Neladalkib for Previously Treated Advanced ALK-Positive NSCLC
3
FDA Fast Tracks Elticertinib for Previously Treated EGFR Exon 20 NSCLC
4
Oncologists Weigh Age and Drug Interactions in mHSPC Treatment Selection
5
